ClearPoint Neuro (CLPT) Gross Margin (2011 - 2026)

ClearPoint Neuro has disclosed Gross Margin across 15 years of filings, most recently posting 61.67% for Q2 2026.

• In Q2 2026, Gross Margin rose 138.0% year-over-year to 61.67%; the TTM figure through Jun 2026 stood at 62.61% (up 219.0% YoY), while the FY2025 annual figure was 61.38%, up 46.0% from the prior year.
• Gross Margin came in at 61.67% for Q2 2026 at ClearPoint Neuro, down from 63.95% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 71.49% in Q3 2022 to a low of 52.54% in Q2 2023.
• Average Gross Margin over 5 years is 61.41%, with a median of 61.4% recorded in 2025.
• Year-over-year, Gross Margin slumped 1469 bps in 2023 and soared 1094 bps in 2024.
• Over 5 years, Gross Margin stood at 65.06% in 2022, then fell by 9 bps to 58.93% in 2023, then grew by 4 bps to 61.28% in 2024, then grew by 0 bps to 61.52% in 2025, then advanced by 0 bps to 61.67% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 61.67% in Q2 2026, 63.95% in Q1 2026, and 61.52% in Q4 2025.